Female genital schistosomiasis burden and risk factors in two endemic areas in Malawi nested in the Morbidity Operational Research for Bilharziasis Implementation Decisions (MORBID) cross-sectional study
Fig 3
Village level prevalence of (A) ‘Molecular-FGS’, (B) ‘Visual-FGS’ by EVA MobileODT hand-held colposcopy, and (C) ‘Visual-FGS by Smart-Scope assessment (C) in women enrolled in the MORBID-FGS study vs village level prevalence of urine egg-positive S. haematobium in school aged children (SAC) enrolled in the main MORBID study.